Guggenheim Reiterates Buy on Assembly Biosciences, Maintains $43 Price Target
Assembly Biosciences Inc ASMB
$27.66
▼ -0.25%
($-0.07)
Open
$27.73
Prev Close
$27.73
Day Range
$27.25 – $28.52
52W Range
$13.81 – $39.71
Market Cap
$439.59M
Beta
1.08
EPS (TTM)
$-1.29
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-12-17 |
| Shares Out. | 15,890,000 |
| Website | assemblybio.com/ ↗ |
| Phone | 18009279800 |
Assembly Biosciences Inc is a publicly traded company under the ticker symbol ASMB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-05-01)
📰 Latest News for ASMB
Crude Oil Edges Higher; US Consumer Sentiment Falls In May
Zoom Upbeat Q1 Results, Joins Lionsgate Studios, Ross Stores And Other Big Stocks Moving Higher On Friday
Assembly Biosciences Prices $100M Offering Of 3,358,602 At $26.50 Per Share And Warrants To Purchase Up To 415,000 Shares At Offer Price Of $26.499 Per Pre-Funded Warrant
Assembly Biosciences Announces Plans To Expand Clinical Development Of ABI-6250 Into Primary Biliary Cholangitis And Primary Sclerosing Cholangitis